CJC-1295 + Ipamorelin Stack: The Complete Growth Hormone Guide

By Verum Health Medical Team  ·  April 1, 2026  ·  9 min read

CJC-1295 combined with Ipamorelin is consistently one of the most prescribed peptide stacks in physician-supervised optimization programs. It's not the flashiest — it doesn't produce rapid, dramatic weight loss the way GLP-1 agonists do, and it doesn't heal injuries as visibly as BPC-157. What it does is restore and enhance the natural growth hormone pulsatility that declines with age, producing gradual but significant improvements in body composition, sleep quality, recovery, and metabolic function.

Here's everything you need to know about how this stack works, how to use it properly, and what to realistically expect.

Understanding the Two Peptides

CJC-1295 and Ipamorelin work through different but complementary mechanisms — which is exactly why they're stacked together.

CJC-1295 is a GHRH analogue — it mimics growth hormone-releasing hormone, the signal your hypothalamus sends to your pituitary to produce growth hormone. CJC-1295 with DAC (Drug Affinity Complex) has an extended half-life of 6–8 days, meaning once-weekly or twice-weekly dosing is sufficient. CJC-1295 without DAC has a shorter half-life (~30 minutes) and is typically used for immediate pulsatile GH release when injected. Most physician-prescribed protocols use CJC-1295 with DAC for convenience and stable GH elevation.

Ipamorelin is a GHRP (growth hormone-releasing peptide) and selective ghrelin receptor agonist. It stimulates the pituitary to release growth hormone through a different receptor pathway than CJC-1295 — the ghrelin receptor. Ipamorelin is considered the "cleanest" GHRP available because it's highly selective: it stimulates GH release without significantly elevating cortisol or prolactin the way older GHRPs like GHRP-6 do. This selectivity is important for long-term use.

The combination is powerful because you're hitting the GH axis from two angles simultaneously — GHRH stimulation (CJC-1295) plus ghrelin receptor stimulation (Ipamorelin). The synergy produces GH pulses that are significantly higher than either peptide alone.

What Growth Hormone Actually Does

GH peaks naturally in your mid-twenties and declines roughly 15% per decade after that. By age 40, most people have roughly half the GH output they had at 25. This decline contributes to:

• Increased visceral fat accumulation, particularly around the abdomen
• Decreased lean muscle mass and slower recovery from exercise
• Reduced sleep quality — especially slow-wave (deep) sleep, where natural GH pulses are largest
• Thinner skin, reduced collagen density, and slower wound healing
• Lower IGF-1 levels, which affects tissue repair throughout the body
• Reduced bone density over time

CJC-1295/Ipamorelin doesn't introduce synthetic growth hormone — it stimulates your own pituitary to produce more GH through natural pulsatile secretion. This distinction matters both for safety (you maintain the feedback regulation that prevents excess) and for efficacy (pulsatile GH is more physiologically appropriate than a flat exogenous dose).

Dosing Protocol

For women, starting Ipamorelin at 100–200mcg is advisable given naturally higher baseline GH levels. Your physician will adjust based on your IGF-1 response at the 6-week check.

The Pulsatile Protocol (CJC-1295 without DAC)

Some physicians prefer CJC-1295 without DAC for more targeted use — particularly for athletes wanting pre-workout or pre-sleep GH pulses rather than continuous elevation. The tradeoff is more frequent injections (2–3x daily instead of twice weekly). The benefit is more physiologically accurate pulsatile secretion.

• CJC-1295 no DAC: 100–200mcg per injection
• Ipamorelin: 200–300mcg per injection
• Inject together 2–3x daily (morning fasted, post-workout, bedtime)

For most patients, the twice-weekly DAC version is simpler and produces equivalent long-term results. The no-DAC protocol is better suited for performance-focused patients who want precise GH pulse timing.

What to Expect: A Month-by-Month Timeline

• Month 1: Improved sleep depth is typically the first noticeable change — deeper slow-wave sleep, more vivid dreams, waking feeling more rested. Some patients notice mild water retention in the first 2 weeks as IGF-1 rises.
• Month 2: Recovery from exercise improves noticeably. Muscle soreness resolves faster. Some patients see early improvements in body composition — fat mass slightly down, lean mass slightly up.
• Month 3: Body composition changes become more measurable. Skin quality and texture often improve (increased collagen synthesis). Energy levels more consistent throughout the day.
• Months 4–6: Most pronounced body composition changes occur here. Patients on concurrent resistance training programs see the most significant lean mass gains and fat loss.

This is not a quick-fix protocol. The changes are real and cumulative, but they require patience and consistency. Patients who skip injections or stop early rarely see the full benefit.

Side Effects and Safety

CJC-1295/Ipamorelin is considered one of the safest growth hormone protocols available. Common side effects are mild and typically self-resolve:

• Water retention: Common in weeks 1–3 as IGF-1 rises. Usually resolves as the body adjusts. Reducing sodium intake helps.
• Injection site reactions: Mild redness or swelling at injection site. Rotating sites prevents buildup.
• Tingling or numbness in hands: Rare; sign of carpal tunnel-like fluid shifts. Reduce dose temporarily.
• Increased hunger: Ipamorelin is a ghrelin agonist — some patients notice appetite increases. Less pronounced than older GHRPs like GHRP-6.

The key safety parameter monitored is IGF-1. Supraphysiologic IGF-1 levels are associated with increased cancer risk in epidemiological studies. This is why all Verum Health GH protocols include mandatory IGF-1 lab monitoring. Target range is upper-normal for age — not supraphysiologic.

Stacking with Other Protocols

CJC-1295/Ipamorelin pairs well with:

• GLP-1 weight loss protocols — GH optimization and GLP-1 agonism address body composition from different angles; combined results are additive
• BPC-157 — enhanced recovery and tissue repair on top of GH-driven anabolism
• NAD+ protocols — mitochondrial optimization complements the metabolic benefits of GH restoration

Ready to see if this protocol is right for you? View our full growth hormone protocol options →